Overview

Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

Status:
Withdrawn
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
To determine the efficacy of open -label transdermal patch on chronic nausea and emesis in patients with gastroparesis
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University
Collaborator:
Kyowa Kirin
Treatments:
Granisetron